You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
寶萊特(300246.SZ):血液透析濃縮液獲醫療器械註冊證
格隆匯 12-16 18:40

格隆匯12月16日丨寶萊特(300246.SZ)公佈,公司的血液透析濃縮液產品於近日獲得國家藥品監督管理局(“國家藥監局”)頒發的《醫療器械註冊證》,註冊證有效期為2019年12月4日至2024年12月3日;血液透析濃縮液適用於急慢性腎衰竭患者的血液透析治療。

目前,公司擁有天津摯信鴻達、遼寧恆信生物、常州華嶽、武漢柯瑞迪共四大血液透析粉/液生產企業,涵蓋了全國包括東北、華北、華東和華中等地區,通過公司渠道及旗下三家渠道平台公司,公司旗下血液透析粉/液等產品已覆蓋國內大部分醫院及血液透析中心,實現了國內市場份額領先。

此次公司獲得血液透析濃縮液的醫療器械註冊證,實現公司血液透析粉/液生產基地在華南地區的突破,將充分發揮珠海總部既有優勢,加快實現公司腎科醫療板塊發展戰略。同時將為公司國內銷售平台與渠道提供更多產品,更大程度發揮公司現有渠道與銷售網絡優勢、協同效果,更快推動公司在血液淨化業務領域做強做大,對公司的發展產生積極影響。

此次公司獲得血液透析濃縮液的醫療器械註冊證,將加快公司在“醫療器械註冊人制度”方面的實行進程,為進一步加快完善公司血液透析粉/液生產基地在全國佈局發揮重要作用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account